Telehealth

Death rates fall, but a new report reveals rising incidence and stark inequities. Can new drugs and AI reshape the future for all patients?

With tooth decay as the #1 childhood disease, Georgia dentists are launching a statewide blitz of free care and education to protect kids' smiles.

A C$20M investment validates Corus's unique doctor-led model, fueling a major expansion across the booming North American orthodontic market.

Mercy hires Google Health veteran Lina Scroggins as its new Chief Product Officer, betting on Silicon Valley expertise to fix the digital patient journey.

With home health aide costs nearing $78,000 annually, families face a financial maze. Learn key strategies for creating a realistic budget for senior care.

A new campaign from ZOLL LifeVest and the AHA targets the deadly disparity in women's cardiac care, blending advocacy with life-saving wearable technology.

A new liquid biopsy more accurately predicts cancer recurrence than standard methods, offering new hope and clarity for patients after surgery.

At MD&M West 2026, Boyd showcases how materials science and regulatory expertise are the unsung heroes behind the next wave of medical wearables.

Boston Marathon survivor Marc Fucarile brings his mobility awareness network to Radio Row, backed by a national painting company's strategic sponsorship.

DXC Technology opens a major AI hub in Sofia, leveraging Bulgaria's booming tech talent to scale enterprise AI solutions for clients worldwide.

A new FAIR Health report finds 57.5% of commercially insured Americans have a chronic condition, with costs nearly doubling for patients with just one.

After its stock plummeted post-IPO, Chinese health-tech firm POMDOCTOR faces a Nasdaq delisting threat, forcing a reckoning with its massive losses.

Canadian provider Airmedic secures a top European accreditation, validating its high standards in safety and patient care for international medical flights.

Early clinical results for MP0712, a novel Radio-DARPin, suggest a breakthrough for targeting aggressive cancers like SCLC while sparing healthy tissue.

Promising Phase 2 data for a potential first-in-class neuropathic corneal pain therapy to be showcased, offering new hope for a debilitating condition.

Incyte's Zynyz gets a key EU panel's nod, offering a breakthrough for advanced anal canal cancer patients after decades of limited treatment options.

The global fitness giant is exploring a Wall Street listing and launching a DNA-based longevity program, signaling a major push for market leadership.

Calian Group prepares to unveil its Q1 FY2026 results, with investors keenly watching for signs of sustained growth and strategic progress in key sectors.

Singapore's first Global Health Film Festival uses powerful storytelling to tackle pandemic preparedness and the growing climate-health crisis in Asia.

A new partnership gives Texas small business employees free access to a clinically proven virtual program aimed at reversing Type 2 diabetes, not just managing it.